Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Eton Pharmaceuticals Inc shares valued at $631,565 were sold by Gruber James R. on Aug 19 ’25. At $16.16 per share, Gruber James R. sold 39,082 shares. The insider’s holdings dropped to 205,299 shares worth approximately $3.32 million following the completion of this transaction.
Also, Gruber James R. sold 2,631 shares, netting a total of over 42,149 in proceeds. Following the sale of shares at $16.02 each, the insider now holds 204,753 shares.
Before that, Gruber James R. had added 41,713 shares to its account. In a trade valued at $692,645, the Officer bought Eton Pharmaceuticals Inc shares for $16.61 each.
As published in a research note from H.C. Wainwright on January 23, 2025, Eton Pharmaceuticals Inc [ETON] has been retained to a Buy and the price target has been revised to $33. Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of January 06, 2025, H.C. Wainwright has reiterated its “Buy” rating for ETON.
Analyzing ETON Stock Performance
On last trading session, Eton Pharmaceuticals Inc [NASDAQ: ETON] plunged -0.55% to $16.19. The stock’s lowest price that day was $16.09, but it reached a high of $16.565 in the same session. During the last five days, there has been a drop of approximately -3.75%. Over the course of the year, Eton Pharmaceuticals Inc shares have jumped approximately 44.17%. Shares of the company reached a 52-week high of $23.00 on 09/30/25 and a 52-week low of $11.09 on 04/07/25.
Support And Resistance Levels for Eton Pharmaceuticals Inc (ETON)
According to the 24-hour chart, there is a support level at 16.00, which, if violated, would cause prices to drop to 15.81. In the upper region, resistance lies at 16.47. The next price resistance is at 16.76. RSI (Relative Strength Index) is 37.76 on the 14-day chart, showing neutral technical sentiment.
Is Eton Pharmaceuticals Inc subject to short interest?
Stocks of Eton Pharmaceuticals Inc saw a sharp steep in short interest on 2025-11-14 dropping by -0.24 million shares to 2.78 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 3.02 million shares. A decline of -8.55% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 10.28 of the overall float, the days-to-cover ratio (short ratio) decline to 10.28.
Which companies own the most shares of Eton Pharmaceuticals Inc (ETON)?
In terms of Eton Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 35 in the next 12 months, up nearly 114.99% from the previous closing price of $16.28. Analysts anticipate Eton Pharmaceuticals Inc stock to reach 35 by 2025, with the lowest price target being 35. In spite of this, 1 analysts ranked Eton Pharmaceuticals Inc stock as Buy at the end of 2025. On May 06, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $8.
